Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00995176 · ClinicalTrials.gov registry record
The Women's HIV SeroIncidence Study (ISIS)
A clinical trial, sponsored by HIV Prevention Trials Network.
- Completed
- Registry status
- 2,099
- Enrollment target
NCT00995176: Completed study, sponsored by HIV Prevention Trials Network.
NCT00995176 is a clinical trial that has completed, run by HIV Prevention Trials Network. The registered enrollment target is 2,099 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00995176 has completed, sponsored by HIV Prevention Trials Network.
- COMPLETED
- Registry status
- 2,099 participants
- Enrollment target
Study Summary
Approximately 30 percent of new HIV infections in the Unites States occur in women, with a disproportionate number occurring in women of color. This observational study has been designed to help determine the HIV incidence among women in the study communities as well as to identify steps that women can take to lower their HIV-infection risk.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,099 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-03 |
What the finished NCT00995176 record still lists
NCT00995176 is an observational study that tracks outcomes without assigning an intervention. Its 2,099 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00995176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00995176 about?
NCT00995176 is a clinical study titled "The Women's HIV SeroIncidence Study (ISIS)". Approximately 30 percent of new HIV infections in the Unites States occur in women, with a disproportionate number occurring in women of color. This observational study has been designed to help determine the HIV incidence among women in the study communities as well as to identify steps that women ...
What is the current status of trial NCT00995176?
This trial is currently completed. The enrollment target is 2,099 participants. The study started on 2009-04. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT00995176?
This trial is sponsored by HIV Prevention Trials Network, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
- NCT06324981 · 2,100 participants · NA
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia